Search

Your search keyword '"Ohki, Kentaro"' showing total 425 results

Search Constraints

Start Over You searched for: Author "Ohki, Kentaro" Remove constraint Author: "Ohki, Kentaro"
425 results on '"Ohki, Kentaro"'

Search Results

1. Finding Quantum Codes via Riemannian Optimization

2. Low-rank approximated Kalman filter using Oja's principal component flow for discrete-time linear systems

3. Low-rank approximated Kalman-Bucy filters using Oja's principal component flow for linear time-invariant systems

4. Exploring the Robustness of stabilizing controls for stochastic quantum evolutions

5. JCCG ALL-B12: Evaluation of Intensified Therapies With Vincristine/Dexamethasone Pulses and Asparaginase and Augmented High-Dose Methotrexate for Pediatric B-ALL

6. A smoothing theory for open quantum systems: The least mean square approach

7. A proposal of adaptive parameter tuning for robust stabilizing control of $N$--level quantum angular momentum systems

8. Threshold theorem in isolated quantum dynamics with stochastic control errors

9. Clinical characteristics and outcomes of B-cell precursor ALL with MEF2D rearrangements: a retrospective study by the Ponte di Legno Childhood ALL Working Group

11. Genome-wide DNA methylation analysis in pediatric acute myeloid leukemia

12. NUDT15 variants confer high incidence of second malignancies in children with acute lymphoblastic leukemia

14. Clinical characteristics and outcomes of B-ALL with ZNF384 rearrangements: a retrospective analysis by the Ponte di Legno Childhood ALL Working Group

15. Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study

17. High DOCK1 expression identifies a distinct prognostic subgroup of pediatric acute myeloid leukemia: Results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML‐05 trial.

18. Landscape of driver mutations and their clinical impacts in pediatric B-cell precursor acute lymphoblastic leukemia

20. Rituximab-combined anthracycline-free chemotherapy in newly diagnosed paediatric and adolescent patients with non-high-risk aggressive mature B cell lymphoma: protocol for a single-arm, open-label, multicentre, phase II study (the Japan Children’s Cancer Group Multicentre Trial, JPLSG B-NHL-20)

23. DNA methylation-based classification reveals difference between pediatric T-cell acute lymphoblastic leukemia and normal thymocytes

24. Transcriptome analysis offers a comprehensive illustration of the genetic background of pediatric acute myeloid leukemia

25. Quantum-enhanced optical phase tracking

26. Rituximab with standard LMB chemotherapy in pediatric high‐risk mature B‐cell non‐Hodgkin lymphoma: A report from the JPLSG B‐NHL14 trial.

29. Genome-wide assessment of genetic risk loci for childhood acute lymphoblastic leukemia in Japanese patients

31. Intragenic amplification of PAX5: a novel subgroup in B-cell precursor acute lymphoblastic leukemia?

32. Treatment outcome of children with acute lymphoblastic leukemia: the Tokyo Children’s Cancer Study Group (TCCSG) Study L04-16

34. Supplementary Table from A Hyperactive RelA/p65-Hexokinase 2 Signaling Axis Drives Primary Central Nervous System Lymphoma

35. Data from A Hyperactive RelA/p65-Hexokinase 2 Signaling Axis Drives Primary Central Nervous System Lymphoma

36. Supplementary Figure from A Hyperactive RelA/p65-Hexokinase 2 Signaling Axis Drives Primary Central Nervous System Lymphoma

37. Data from Recurrent RARB Translocations in Acute Promyelocytic Leukemia Lacking RARA Translocation

38. Supplementary Data from A Hyperactive RelA/p65-Hexokinase 2 Signaling Axis Drives Primary Central Nervous System Lymphoma

39. Supplementary Information from Recurrent RARB Translocations in Acute Promyelocytic Leukemia Lacking RARA Translocation

41. Pediatric follicular lymphoma in Japan

42. UBTF ‐internaltandem duplication as a novel poor prognostic factor in pediatric acute myeloid leukemia

44. Prognosis of Pediatric Acute Myeloid Leukemia with KMT2A-MLLT3 According to DNA Methylation Patterns: Jccg JPLSG AML-05 Study

45. Clinical characteristics and outcomes of B-cell precursor ALL with MEF2D rearrangements: a retrospective study by the Ponte di Legno Childhood ALL Working Group

49. Labile CD22 and CD19 expression in a case of Philadelphia chromosome-like acute lymphoblastic leukemia

50. A phase III clinical trial evaluating efficacy and safety of minimal residual disease-based risk stratification for children with acute myeloid leukemia, incorporating a randomized study of gemtuzumab ozogamicin in combination with post-induction chemotherapy for non-low-risk patients (JPLSG-AML-20)

Catalog

Books, media, physical & digital resources